藥 物 回 收
|
| |
| Singapore: Recall of Januvia 100mg Tablet (English only) |
| |
Health Sciences Authority (HSA) announces that MSD Pharma (Singapore) Pte Ltd is recalling one batch of Januvia 100mg Tablet (sitagliptin) (batch number: U014152) to the retail level. During recent testing, an impurity, nitroso-STG-19 (also known as NTTP), was found to be above the acceptable level in the affected batch.
Please refer to the following website in HSA for details:
http://www.hsa.gov.sg/announcements/product-recall/recall-of-januvia-100mg-tablet
In Hong Kong, Januvia Tab 100mg (HK-56094) is a pharmaceutical product registered by Merck Sharp & Dohme (Asia) Ltd (MSD). The product is a prescription-only medicine. As confirmed with MSD, the affected batch has not been imported into Hong Kong.
Ends/Wednesday, Dec 14, 2022
Issued at HKT 16:00
|
| |
|
